Wednesday, 4 June 2014
Princess Health and Princess Health andStudy: Banning sugary drinks from SNAP would reduce obesity and Type 2 diabetes; subsidy would boost fruit consumption.Princessiccia
diabetes food stamps fruit nutrition obesity research sugar vegetablesA measure preventing people from purchasing sugar-sweetened beverages through the Supplemental Nutrition Assistance Program, or food stamps, would significantly reduce obesity and Type 2 diabetes in adults under 65, and adding a subsidy for fruits and vegetables would more than double the number of SNAP participants who meet federal vegetable and fruit consumption guidelines, says a new study published in Health Affairs.
Research has shown that people on food stamps suffer diabetes, heart disease and obesity at higher rates than people who are in the same tax bracket but not on food stamps, Diane Jeanty reports for PBS Newshour. In 2013, these findings prompted 18 mayors from major U.S. cities to write to Congress with a push to ban the use of food stamps to purchase sugar sweetened beverages.
The American Beverage Association pushed back, saying "sugared beverages were being targeted and were not the only causes for obesity," Jeanty writes.
A research team led by Dr. Sanjay Basu, an assistant professor of medicine at the Stanford University School of Medicine, conducted the study to determine how banning sugared beverages could affect the SNAP population�s level of risk for these diseases, Jeanty reports. They used a survey by the federal Centers for Disease Control, which assesses the nutritional status of adults and children, and combined it with current information on SNAP.
The study had two models, one that banned sugary beverages�excluding 100 percent fruit juice�and another that offered an incentive for SNAP participants to receive a 30 cent credit for each dollar spent on fruit and vegetable purchases. The study factored in metabolism rates and demographics such as race, age, gender and income to test the effects of the proposed measures, Jeanty reports.
They found that with a simulated ban, a person would reduce his or her calorie intake by 24 per day. They also found that obesity rates decreased 2.4 percent and type 2 Diabetes rates dropped 1.7 percent�or 240,000 people�Jeanty reports. The simulated subsidy, did not, however, have a significant impact on overall diabetes and obesity.
The study also found that by adding a simulated subsidy on fruits and vegetables, SNAP participants increased their consumption from 1/4 cup to 3 cups per day. However, increasing the amount of fruits and vegetables consumed is not enough to influence the reduction of diabetes and obesity on a national scale, according to Basu. �There would also have to be further reforms to also reduce the consumption of sugary beverages,� Basu told Jeanty.
The Illinois Public Health Institute, addressing a proposed ban in Illinois, found that SNAP participants would still purchase sugared beverages with their own money, even if they were banned, Jeanty reports. But Basu says that his study accounted for this consideration. Basu said it is time to perform a controlled study instead of a simulation model, Jeanty writes.
Research has shown that people on food stamps suffer diabetes, heart disease and obesity at higher rates than people who are in the same tax bracket but not on food stamps, Diane Jeanty reports for PBS Newshour. In 2013, these findings prompted 18 mayors from major U.S. cities to write to Congress with a push to ban the use of food stamps to purchase sugar sweetened beverages.
The American Beverage Association pushed back, saying "sugared beverages were being targeted and were not the only causes for obesity," Jeanty writes.
A research team led by Dr. Sanjay Basu, an assistant professor of medicine at the Stanford University School of Medicine, conducted the study to determine how banning sugared beverages could affect the SNAP population�s level of risk for these diseases, Jeanty reports. They used a survey by the federal Centers for Disease Control, which assesses the nutritional status of adults and children, and combined it with current information on SNAP.
The study had two models, one that banned sugary beverages�excluding 100 percent fruit juice�and another that offered an incentive for SNAP participants to receive a 30 cent credit for each dollar spent on fruit and vegetable purchases. The study factored in metabolism rates and demographics such as race, age, gender and income to test the effects of the proposed measures, Jeanty reports.
They found that with a simulated ban, a person would reduce his or her calorie intake by 24 per day. They also found that obesity rates decreased 2.4 percent and type 2 Diabetes rates dropped 1.7 percent�or 240,000 people�Jeanty reports. The simulated subsidy, did not, however, have a significant impact on overall diabetes and obesity.
The study also found that by adding a simulated subsidy on fruits and vegetables, SNAP participants increased their consumption from 1/4 cup to 3 cups per day. However, increasing the amount of fruits and vegetables consumed is not enough to influence the reduction of diabetes and obesity on a national scale, according to Basu. �There would also have to be further reforms to also reduce the consumption of sugary beverages,� Basu told Jeanty.
The Illinois Public Health Institute, addressing a proposed ban in Illinois, found that SNAP participants would still purchase sugared beverages with their own money, even if they were banned, Jeanty reports. But Basu says that his study accounted for this consideration. Basu said it is time to perform a controlled study instead of a simulation model, Jeanty writes.
Tuesday, 3 June 2014
Princess Health and Princess Health andHealth foundation chief objects to bill that would allow school districts to get waivers from recent nutrition standards.Princessiccia
children's health Congress diet fruit obesity school lunch schools vegetablesThe president of Kentucky's public-interest health foundation is objecting to legislation recently approved by the U.S. House Appropriations Committee to allow waivers from the school nutrition enacted by the Department of Agriculture in 2010.
Susan G. Zepeda of the Foundation for a Healthy Kentucky says in a statement sent to Kentucky news media that the foundation's polls show that Kentuckians "want healthier foods in the schools," but fewer than one in four Kentucky adults "described the meals at their children's school or daycare as 'very nutritious'."
Zepeda notes that the Data Resource Center for Child and Adolescent Health showed that 35.7 percent of Kentucky children were either overweight or obese in 2011-12, that children living in poverty are more likely to be obese, and that polls show Kentucky adults think childhood obesity is a serious issue, and 78 percent of them approved of the new USDA meal standards, Zepeda notes.
The legislation would allow school districts that have lost money on meals for six months to ask for a waiver from the standards. Zepeda said "the major voice" for the bill was the School Nutrition Association, "a trade group of school food officials backed by such food companies as Coca-Cola, Domino�s Pizza and PepsiCo," but "19 of the association�s former presidents have called on Congress to reject the waiver. We add our voice to this call."
 |
| Susan G. Zepeda, Ph.D. |
Zepeda notes that the Data Resource Center for Child and Adolescent Health showed that 35.7 percent of Kentucky children were either overweight or obese in 2011-12, that children living in poverty are more likely to be obese, and that polls show Kentucky adults think childhood obesity is a serious issue, and 78 percent of them approved of the new USDA meal standards, Zepeda notes.
The legislation would allow school districts that have lost money on meals for six months to ask for a waiver from the standards. Zepeda said "the major voice" for the bill was the School Nutrition Association, "a trade group of school food officials backed by such food companies as Coca-Cola, Domino�s Pizza and PepsiCo," but "19 of the association�s former presidents have called on Congress to reject the waiver. We add our voice to this call."
Princess Health and Princess Health andUK awarded $1.9 million to improve recruitment, preparation and retention of science, tech, engineering and math students.Princessiccia
education philanthropyThe Howard Hughes Medical Institute has awarded the University of Kentucky a five-year, $1.9 million grant to improve retention of students in the STEM disciplines: science, technology, engineering and mathematics, through a collection of initiatives dubbed "STEMCats."
The STEMCats project will feature five key components, each aimed at improving the recruitment, preparation and retention of STEM majors: FastTrack courses for Math, Biology, Chemistry and Physics to better prepare incoming students; a STEMCats living learning community; a freshman STEM research course; a team-based summer research experience and an improved introductory STEM curriculum.
Fewer than half of all students who enter college with the intention of majoring in a STEM field leave with a STEM degree, according to the university's press release. Nationwide, 40 percent of students enroll in a STEM program when they enter college, and the rate drops to roughly 20 percent among historically under-represented ethnic groups.
Many first-year college students are not prepared for the rigors of college-level science and math, Professor Vincent Cassone, chair of the UK Department of Biology and STEMCats project director, said in the release. "They have no idea what to expect, and I think it comes as a shock to some of them just how much work is actually involved in passing an introductory-level STEM class," Cassone said in the release. "By the time they realize it, they may already be in trouble. It's not that they can't do the work. They just are not mentally and psychologically prepared for the challenges they face at the university level. The STEMCats initiatives are designed to help students get ready to succeed."
UK is partnering on these initiatives with Bluegrass Community and Technical College, which will allow these students "to work in UK research facilities, live in STEM-designated communities at UK and be part of a FastTrack student cohort designed to remove barriers of success while enhancing STEM opportunities and knowledge," Tammy Liles, associate STEMCats project director, said in the release.
UK is one of 37 research institutions to receive an award, from among 170 institutions competing for a share of $60 million in total funding, according to the release. (Read more)
The STEMCats project will feature five key components, each aimed at improving the recruitment, preparation and retention of STEM majors: FastTrack courses for Math, Biology, Chemistry and Physics to better prepare incoming students; a STEMCats living learning community; a freshman STEM research course; a team-based summer research experience and an improved introductory STEM curriculum.
Many first-year college students are not prepared for the rigors of college-level science and math, Professor Vincent Cassone, chair of the UK Department of Biology and STEMCats project director, said in the release. "They have no idea what to expect, and I think it comes as a shock to some of them just how much work is actually involved in passing an introductory-level STEM class," Cassone said in the release. "By the time they realize it, they may already be in trouble. It's not that they can't do the work. They just are not mentally and psychologically prepared for the challenges they face at the university level. The STEMCats initiatives are designed to help students get ready to succeed."
UK is partnering on these initiatives with Bluegrass Community and Technical College, which will allow these students "to work in UK research facilities, live in STEM-designated communities at UK and be part of a FastTrack student cohort designed to remove barriers of success while enhancing STEM opportunities and knowledge," Tammy Liles, associate STEMCats project director, said in the release.
UK is one of 37 research institutions to receive an award, from among 170 institutions competing for a share of $60 million in total funding, according to the release. (Read more)
Monday, 2 June 2014
Princess Health and Princess Health andDanville is latest Ky. community to ban indoor use of e-cigarettes, following new law that classifies them as tobacco product.Princessiccia
e-cigarettes local government smoking smoking ban state governmentThe Danville City Commission has approved an ordinance that bans the use of e-cigs in enclosed places, placing the same restrictions on them that already exist on traditional tobacco cigarettes, though the health risk of e-cigs has not yet been determined, Todd Kleffman reports for The Advocate-Messenger.
Kleffman notes that Danville is among a few Kentucky communities leading the way on placing restrictions on e-cigs, which are battery-powered devices that emit vaporized nicotine, but not tobacco.
"Bardstown, Manchester and Madison County have placed an outright ban on public use of e-cigs, while Kenton County prohibits their use in the workplace, and Glasgow bans them in bars and restaurants, according to attorney Chris Johnson of the Kentucky League of Cities," Kleffman writes.
E-cigs have become increasingly popular as an alternative to smoking, and because the amount of nicotine can be adjusted in the vapor liquid, many use it as a means to quit smoking, although this claim has not been proven.
�Generally, it�s people who are trying to quit smoking or are looking for a cheaper, healthier, less offensive alternative,� Blayne Hogue, operator of Vapor Visions in Danville, told Kleffman. �With the younger crowd it has appeal because of the taste and because it�s kind of the new thing.�
Speaking to the concern that vaporizing products with a "candy store array of flavors carrying names like Skittles, Pluto, Mother�s Milk and John Wayne" is designed to appeal to an underage crowd, Eric Griffiths, proprietor of the e-cig store Juice Box, asked, �Why is that we have to be marketing to kids because it has flavors? Just because it�s an adult product doesn�t mean it has to taste bad.�
Neither store allows minors.
The U.S. Food and Drug Administration announced last month that it will begin regulating e-cigs in the future, Kleffman notes, and the Kentucky General Assembly passed a law this year that puts
vapor products in the same class as tobacco cigarettes, prohibiting their sale to those under 18.
The state law, not complaints from local business owners or residents, is what prompted the Danville City Commission to enact its own ordinance banning e-cigs in enclosed public places, City Manager Ron Scott told Kleffman.
�The state now classifies them as a tobacco product. What makes them different? By our ordinance, there is no distinction,� Scott said to Kleffman. �You can�t have it both ways. We had to clarify it for our businesses as to where they can be used. Vapor products contain nicotine, and from a public health point of view, there is an unknown amount of nicotine in the exhaled vapor that could affect others, like second-hand smoke. . . . Do you err on the side of caution, or do you just disregard the potential public health risks?"
The commission vote was 3-2, with Mayor Bernie Hunstad and Commissioner Kevin Caudill voting against the ban after two citizens argued that the prohibition was premature because no reliable research has proven that the devices create a public health concern.
Kleffman notes that Danville is among a few Kentucky communities leading the way on placing restrictions on e-cigs, which are battery-powered devices that emit vaporized nicotine, but not tobacco."Bardstown, Manchester and Madison County have placed an outright ban on public use of e-cigs, while Kenton County prohibits their use in the workplace, and Glasgow bans them in bars and restaurants, according to attorney Chris Johnson of the Kentucky League of Cities," Kleffman writes.
E-cigs have become increasingly popular as an alternative to smoking, and because the amount of nicotine can be adjusted in the vapor liquid, many use it as a means to quit smoking, although this claim has not been proven.
�Generally, it�s people who are trying to quit smoking or are looking for a cheaper, healthier, less offensive alternative,� Blayne Hogue, operator of Vapor Visions in Danville, told Kleffman. �With the younger crowd it has appeal because of the taste and because it�s kind of the new thing.�
Speaking to the concern that vaporizing products with a "candy store array of flavors carrying names like Skittles, Pluto, Mother�s Milk and John Wayne" is designed to appeal to an underage crowd, Eric Griffiths, proprietor of the e-cig store Juice Box, asked, �Why is that we have to be marketing to kids because it has flavors? Just because it�s an adult product doesn�t mean it has to taste bad.�
Neither store allows minors.
The U.S. Food and Drug Administration announced last month that it will begin regulating e-cigs in the future, Kleffman notes, and the Kentucky General Assembly passed a law this year that puts
vapor products in the same class as tobacco cigarettes, prohibiting their sale to those under 18.
The state law, not complaints from local business owners or residents, is what prompted the Danville City Commission to enact its own ordinance banning e-cigs in enclosed public places, City Manager Ron Scott told Kleffman.
�The state now classifies them as a tobacco product. What makes them different? By our ordinance, there is no distinction,� Scott said to Kleffman. �You can�t have it both ways. We had to clarify it for our businesses as to where they can be used. Vapor products contain nicotine, and from a public health point of view, there is an unknown amount of nicotine in the exhaled vapor that could affect others, like second-hand smoke. . . . Do you err on the side of caution, or do you just disregard the potential public health risks?"
The commission vote was 3-2, with Mayor Bernie Hunstad and Commissioner Kevin Caudill voting against the ban after two citizens argued that the prohibition was premature because no reliable research has proven that the devices create a public health concern.
Princess Health and#TeamMike vs. #TeamDave.Princessiccia
The team draft has finally come and gone! If you don't know what the #MikeVsDave team challenge is, click here to learn more.
Here's how it went down!
(1) Rock, paper, scissors
This was used to determine who gets to call the coin toss. Mike took down Dave's paper, and thus got to call the toss.
(2) Coin Toss
At 6:45pm, the coin was tossed at practice. Mike called tails, and the coin landed tails up. Mike opted to go second in the draft.
(3) Draft
Here is a review of how the draft went as shown on our live twitter feed starting at 9:00pm.
Pick #1: Team Dave takes RunnerRob
Pick #2: Team Mike takes Sean Delanghe
Pick #3: Team Mike takes Brendan Hancock
Pick #4: Team Dave takes Ahmed Ahmed
Pick #5: Team Mike takes IronLuke
Pick #6: Team Dave takes Greg Dyce
Pick #7: Team Mike takes Pat Mulherin
Pick #8: Team Dave takes Chris Goldsworthy
Pick #9: Team Mike takes Nick Burt for his sub
Pick #10: Team Dave's pick is TBA
Who do you think has the better team?
Stay tuned for full info on the rosters!
Here's how it went down!
(1) Rock, paper, scissors
This was used to determine who gets to call the coin toss. Mike took down Dave's paper, and thus got to call the toss.
(2) Coin Toss
At 6:45pm, the coin was tossed at practice. Mike called tails, and the coin landed tails up. Mike opted to go second in the draft.
(3) Draft
Here is a review of how the draft went as shown on our live twitter feed starting at 9:00pm.
Pick #1: Team Dave takes RunnerRob
Pick #2: Team Mike takes Sean Delanghe
Pick #3: Team Mike takes Brendan Hancock
Pick #4: Team Dave takes Ahmed Ahmed
Pick #5: Team Mike takes IronLuke
Pick #6: Team Dave takes Greg Dyce
Pick #7: Team Mike takes Pat Mulherin
Pick #8: Team Dave takes Chris Goldsworthy
Pick #9: Team Mike takes Nick Burt for his sub
Pick #10: Team Dave's pick is TBA
Who do you think has the better team?
Stay tuned for full info on the rosters!
Princess Health and Princess Health andBreakthrough drugs for targeted diseases work wonders, but are very expensive; some see a trend to worry about.Princessiccia
cancer lung cancer pharmaceuticals research skin cancerDrugs focusing on narrow subsets of broader diseases are now being developed for individuals with specific genetic makeups. This trend prompts questions about who covers the cost, who gets the drugs and which diseases get the investment dollars, Brady Dennis reports for The Washington Post.
The newest "breakthrough" pharmaceutical is a new lung cancer drug named Zykadia, Dennis reports. The Food and Drug Administration released it four months ahead of schedule.
This drug is not designed to treat everyone who has lung cancer, which kills an estimated 160,000 Americans each year, including 3,500 Kentuckians. Kentucky's lung cancer death rate is almost 50 percent higher than the U.S. rate, placing Kentucky first in the nation for new cases and deaths from lung cancer.
Zykadia is designed to treat only about 5 percent of patients who fit into a specific subset of the disease: those who have advanced, non-small-cell lung cancer, and a specific gene mutation that causes tumors to resist other treatment, Dennis writes. For them�and only them�the drug has the proven potential to shrink tumors and extend lives.
�It�s a new world,� Wendy Selig, president of the Melanoma Research Alliance, told Dennis. �We�re segmenting what we thought of as large diseases into smaller populations of patients that are defined by genetic distinctions. .?.?. The goal is to match the right therapy to the right patient and to do it with minimal collateral damage.�
Since 2011, the FDA has approved numerous new treatments for melanoma, or skin-cancer patients with certain types of genetic mutations, specific cancers and a small proportion of people with cystic fibrosis, Dennis notes.
The FDA told Dennis that almost 40 of the nearly 50 drugs it has designated as potential �breakthroughs� involve targeted therapies. These targeted therapies often offer recipients earlier and better diagnoses, more effective treatments and even possible cures�or at least more time�for people who previously had little hope.
"But the trend toward targeted medicine also is forcing hard questions on regulators, drug makers, insurers and patients alike: Who should pay for the growing number of specialized drugs, which can cost hundreds of thousands of dollars a year? How does society ensure that everyone who might benefit�rich or poor�can receive treatment? What about patients whose specific conditions or mutations have not attracted investment dollars or the attention of researchers, leaving them to watch and hope from the sidelines?" Dennis writes.
Private insurers and Medicare generally cover the high drug costs, which currently account for only a fraction of overall health-care spending, Dennis reports.
But Barry Werth, an author and journalist who has spent decades writing about the pharmaceutical industry, asks, "What happens when targeted drugs become the rule rather than the exception? Will insurers refuse to cover some of them? Will the government ponder rationing them? Will only the wealthy be able to afford the best and newest treatments?"
This scenario could be happening with Sovaldi, a "groundbreaking new treatment" for the estimated 3 million Americans infected with hepatitis C, Dennis reports. Insurers are publicly rebelling against the drug's price of $1,000 per pill, or $84,000 for a 12-week treatment.
"The worry is that Sovaldi is the poster child for a �tsunami of expensive medicines� that collectively threaten to bankrupt the health-care system," John Rother, president of the National Coalition on Health Care, which represents insurers, employers, consumer and religious groups, health-care providers and some drug manufacturers, told Dennis.
�We�ve been able to absorb it so far because there are very few of them and because they are consumed by very small numbers of people,� Rother said of specialty drugs. �[But] if they�re all priced at the same level Sovaldi is, we really won�t be able to absorb it in the current system. It�s not sustainable.�
Edward Abrahams, president of the Personalized Medicine Coalition, an advocacy organization that includes drug makers, medical providers and patient and research groups, told Dennis that the cost of creating targeted drugs cost billions of dollars and often takes a decade or more to develop. Without the ability to recoup those costs, he said, "research will wither."
�As a society, we�re schizophrenic about this,� Abrahams told Dennis, adding that everyone wants to cure cancer and other diseases. �But at the other end, you have to be willing to pay for these products. .?.?. When you develop a drug for a segmented population, the cost of that drug is likely to be higher than if it worked for everybody.�
The newest "breakthrough" pharmaceutical is a new lung cancer drug named Zykadia, Dennis reports. The Food and Drug Administration released it four months ahead of schedule.
This drug is not designed to treat everyone who has lung cancer, which kills an estimated 160,000 Americans each year, including 3,500 Kentuckians. Kentucky's lung cancer death rate is almost 50 percent higher than the U.S. rate, placing Kentucky first in the nation for new cases and deaths from lung cancer.
Zykadia is designed to treat only about 5 percent of patients who fit into a specific subset of the disease: those who have advanced, non-small-cell lung cancer, and a specific gene mutation that causes tumors to resist other treatment, Dennis writes. For them�and only them�the drug has the proven potential to shrink tumors and extend lives.
�It�s a new world,� Wendy Selig, president of the Melanoma Research Alliance, told Dennis. �We�re segmenting what we thought of as large diseases into smaller populations of patients that are defined by genetic distinctions. .?.?. The goal is to match the right therapy to the right patient and to do it with minimal collateral damage.�
Since 2011, the FDA has approved numerous new treatments for melanoma, or skin-cancer patients with certain types of genetic mutations, specific cancers and a small proportion of people with cystic fibrosis, Dennis notes.
The FDA told Dennis that almost 40 of the nearly 50 drugs it has designated as potential �breakthroughs� involve targeted therapies. These targeted therapies often offer recipients earlier and better diagnoses, more effective treatments and even possible cures�or at least more time�for people who previously had little hope.
"But the trend toward targeted medicine also is forcing hard questions on regulators, drug makers, insurers and patients alike: Who should pay for the growing number of specialized drugs, which can cost hundreds of thousands of dollars a year? How does society ensure that everyone who might benefit�rich or poor�can receive treatment? What about patients whose specific conditions or mutations have not attracted investment dollars or the attention of researchers, leaving them to watch and hope from the sidelines?" Dennis writes.
Private insurers and Medicare generally cover the high drug costs, which currently account for only a fraction of overall health-care spending, Dennis reports.
But Barry Werth, an author and journalist who has spent decades writing about the pharmaceutical industry, asks, "What happens when targeted drugs become the rule rather than the exception? Will insurers refuse to cover some of them? Will the government ponder rationing them? Will only the wealthy be able to afford the best and newest treatments?"
This scenario could be happening with Sovaldi, a "groundbreaking new treatment" for the estimated 3 million Americans infected with hepatitis C, Dennis reports. Insurers are publicly rebelling against the drug's price of $1,000 per pill, or $84,000 for a 12-week treatment.
"The worry is that Sovaldi is the poster child for a �tsunami of expensive medicines� that collectively threaten to bankrupt the health-care system," John Rother, president of the National Coalition on Health Care, which represents insurers, employers, consumer and religious groups, health-care providers and some drug manufacturers, told Dennis.
�We�ve been able to absorb it so far because there are very few of them and because they are consumed by very small numbers of people,� Rother said of specialty drugs. �[But] if they�re all priced at the same level Sovaldi is, we really won�t be able to absorb it in the current system. It�s not sustainable.�
Edward Abrahams, president of the Personalized Medicine Coalition, an advocacy organization that includes drug makers, medical providers and patient and research groups, told Dennis that the cost of creating targeted drugs cost billions of dollars and often takes a decade or more to develop. Without the ability to recoup those costs, he said, "research will wither."
�As a society, we�re schizophrenic about this,� Abrahams told Dennis, adding that everyone wants to cure cancer and other diseases. �But at the other end, you have to be willing to pay for these products. .?.?. When you develop a drug for a segmented population, the cost of that drug is likely to be higher than if it worked for everybody.�
Subscribe to:
Posts (Atom)
Artikel Terpilih
-
The American Red Cross is a storied non-profit organization. It provides disaster relief, provides a major part of the US blood supply, and...
-
From the Associated Press, via the Charlotte Observer, came the story that a mix-up at Duke Health Raleigh and Durham Regional hospitals, b...
-
Healthy Sleep Habits, Happy Child: A Step-By-Step Program For a Good Night's Sleep If You search healthy sleep habits happy child then H...
-
The U.S. Supreme Court is set to hear arguments later this month about the federal health care-reform law, and is expected to decide the law...
-
To the cybernetic idealists out there who think computers are the greatest thing next to sliced bread in the healthcare environment, I say, ...
-
We have posted frequently about the governance and leadership of academic medical organizations. While one would think that health care orga...
-
August 2nd, 2016 Despite Myself Today was one of those days where I wasn't planning on it becoming what it did. It was a busy day! It wa... -
Audrey Tayse Haynes, who is a social worker by training but knows her way around politics, government and the nonprofit world, will be the n... -
Image from Lauren Osborne, WYMT-TV Mountain News By Melissa Patrick Kentucky Health News CORBIN, Ky. � After a day of learning and talkin... -
My Zumba Year � How to start and keep loving your Zumba routine! It's just over a year ago since I started Zumba classes with Lily. I wa...
Widget
